157 related articles for article (PubMed ID: 25038288)
1. Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor.
Tierney BJ; McCann GA; Naidu S; Rath KS; Saini U; Wanner R; Kuppusamy P; Suarez A; Goodfellow PJ; Cohn DE; Selvendiran K
Gynecol Oncol; 2014 Oct; 135(1):133-41. PubMed ID: 25038288
[TBL] [Abstract][Full Text] [Related]
2. Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinoma.
Bixel K; Saini U; Kumar Bid H; Fowler J; Riley M; Wanner R; Deepa Priya Dorayappan K; Rajendran S; Konishi I; Matsumura N; Cohn DE; Selvendiran K
Int J Cancer; 2017 Nov; 141(9):1856-1866. PubMed ID: 28646535
[TBL] [Abstract][Full Text] [Related]
3. HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition.
Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Rivera BK; Kálai T; Hideg K; Kuppusamy P
Cancer Biol Ther; 2011 Nov; 12(9):837-45. PubMed ID: 21885917
[TBL] [Abstract][Full Text] [Related]
4. Anticancer efficacy of a difluorodiarylidenyl piperidone (HO-3867) in human ovarian cancer cells and tumor xenografts.
Selvendiran K; Tong L; Bratasz A; Kuppusamy ML; Ahmed S; Ravi Y; Trigg NJ; Rivera BK; Kálai T; Hideg K; Kuppusamy P
Mol Cancer Ther; 2010 May; 9(5):1169-79. PubMed ID: 20442315
[TBL] [Abstract][Full Text] [Related]
5. High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer.
Wallbillich JJ; Josyula S; Saini U; Zingarelli RA; Dorayappan KD; Riley MK; Wanner RA; Cohn DE; Selvendiran K
PLoS One; 2017; 12(1):e0170318. PubMed ID: 28114390
[TBL] [Abstract][Full Text] [Related]
6. Stat3 activation in human endometrial and cervical cancers.
Chen CL; Hsieh FC; Lieblein JC; Brown J; Chan C; Wallace JA; Cheng G; Hall BM; Lin J
Br J Cancer; 2007 Feb; 96(4):591-9. PubMed ID: 17311011
[TBL] [Abstract][Full Text] [Related]
7. Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells.
Saydmohammed M; Joseph D; Syed V
J Cell Biochem; 2010 May; 110(2):447-56. PubMed ID: 20235152
[TBL] [Abstract][Full Text] [Related]
8. HO-3867, a STAT3 inhibitor induces apoptosis by inactivation of STAT3 activity in BRCA1-mutated ovarian cancer cells.
Tierney BJ; McCann GA; Cohn DE; Eisenhauer E; Sudhakar M; Kuppusamy P; Hideg K; Selvendiran K
Cancer Biol Ther; 2012 Jul; 13(9):766-75. PubMed ID: 22801507
[TBL] [Abstract][Full Text] [Related]
9. Nuclear expression of pSTAT3
Marginean FE; Hellsten R; Krzyzanowska A; Bjartell A
Pathol Res Pract; 2022 Apr; 232():153811. PubMed ID: 35259550
[TBL] [Abstract][Full Text] [Related]
10. Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor.
McCann GA; Naidu S; Rath KS; Bid HK; Tierney BJ; Suarez A; Varadharaj S; Zhang J; Hideg K; Houghton P; Kuppusamy P; Cohn DE; Selvendiran K
Oncoscience; 2014; 1(3):216-28. PubMed ID: 25594014
[TBL] [Abstract][Full Text] [Related]
11. Diarylidenylpiperidones, H-4073 and HO-3867, Induce G2/M Cell-Cycle Arrest, Apoptosis and Inhibit STAT3 Phosphorylation in Human Pancreatic Cancer Cells.
Mast JM; Tse D; Shee K; Lakshmi Kuppusamy M; Kmiec MM; Kálai T; Kuppusamy P
Cell Biochem Biophys; 2019 Jun; 77(2):109-119. PubMed ID: 31089934
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3.
Selvendiran K; Bratasz A; Kuppusamy ML; Tazi MF; Rivera BK; Kuppusamy P
Int J Cancer; 2009 Nov; 125(9):2198-204. PubMed ID: 19623660
[TBL] [Abstract][Full Text] [Related]
13. Anticancer potential of diarylidenyl piperidone derivatives, HO-4200 and H-4318, in cisplatin resistant primary ovarian cancer.
ElNaggar AC; Saini U; Naidu S; Wanner R; Sudhakar M; Fowler J; Nagane M; Kuppusamy P; Cohn DE; Selvendiran K
Cancer Biol Ther; 2016 Oct; 17(10):1107-1115. PubMed ID: 27415751
[TBL] [Abstract][Full Text] [Related]
14. HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer.
Rath KS; Naidu SK; Lata P; Bid HK; Rivera BK; McCann GA; Tierney BJ; Elnaggar AC; Bravo V; Leone G; Houghton P; Hideg K; Kuppusamy P; Cohn DE; Selvendiran K
Cancer Res; 2014 Apr; 74(8):2316-27. PubMed ID: 24590057
[TBL] [Abstract][Full Text] [Related]
15. The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity.
Bill MA; Fuchs JR; Li C; Yui J; Bakan C; Benson DM; Schwartz EB; Abdelhamid D; Lin J; Hoyt DG; Fossey SL; Young GS; Carson WE; Li PK; Lesinski GB
Mol Cancer; 2010 Jun; 9():165. PubMed ID: 20576164
[TBL] [Abstract][Full Text] [Related]
16. Safe and targeted anticancer efficacy of a novel class of antioxidant-conjugated difluorodiarylidenyl piperidones: differential cytotoxicity in healthy and cancer cells.
Selvendiran K; Ahmed S; Dayton A; Kuppusamy ML; Tazi M; Bratasz A; Tong L; Rivera BK; Kálai T; Hideg K; Kuppusamy P
Free Radic Biol Med; 2010 May; 48(9):1228-35. PubMed ID: 20156552
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 11 is upregulated in uterine lavage and endometrial cancer cells in women with endometrial carcinoma.
Yap J; Salamonsen LA; Jobling T; Nicholls PK; Dimitriadis E
Reprod Biol Endocrinol; 2010 Jun; 8():63. PubMed ID: 20553623
[TBL] [Abstract][Full Text] [Related]
18. PIM kinase inhibitors downregulate STAT3(Tyr705) phosphorylation.
Chang M; Kanwar N; Feng E; Siu A; Liu X; Ma D; Jongstra J
Mol Cancer Ther; 2010 Sep; 9(9):2478-87. PubMed ID: 20667852
[TBL] [Abstract][Full Text] [Related]
19. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
Shen L; Zhang G; Lou Z; Xu G; Zhang G
BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727
[TBL] [Abstract][Full Text] [Related]
20. Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target.
Saini U; Naidu S; ElNaggar AC; Bid HK; Wallbillich JJ; Bixel K; Bolyard C; Suarez AA; Kaur B; Kuppusamy P; Hays J; Goodfellow PJ; Cohn DE; Selvendiran K
Oncogene; 2017 Jan; 36(2):168-181. PubMed ID: 27292260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
